Cessation

Ref: AHCL/2026-27/C043 September 29, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 Scrip Code – 544350 Symbol : AGARWALEYE Dear Sir / Madam, Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) - Completion of Tenure of Mr. Sanjay Anand, Independent Director of the Company Ref: Regulation 30(2) read with Sub Clause 7 of Part A, Para A of Schedule III of the SEBI Listing Regulations and SEBI Master Circular no. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 (‘SEBI Master Circular’) Pursuant to the captioned subject and reference, this is to inform that, Mr. Sanjay Anand (DIN: 02501139) will cease to be an Independent Director of the Company, upon completion of his second term of five (5) consecutive years, at the close of business hours today, i.e. September 29, 2026, in accordance with the provisions of Section 149(11) of the Companies Act, 2013, read with Regulation 25 of the SEBI Listing Regulations. The Board of Directors and the Management of the Company express their deep appreciation and gratitude to Mr. Sanjay Anand for his invaluable contribution and guidance during his tenure with the Company. Consequent to the aforesaid cessation of Mr. Sanjay Anand, the revised constitution of the Committees of the Board of Directors of the Company, effective September 29, 2026, is as follows: I. AUDIT COMMITTEE: Position in the Name Designation Committee Mr. Balakrishnan Venkatraman Chairperson Independent Director Non-Executive Non-Independent Mr. Ankur Nand Thadani Member Director Mr. Nachiket Madhusudan Mor Member Independent Director Position in the Name Designation Committee Dr. Ranjan Ramdas Pai Member Independent Director Ms. Archana Bhaskar Member Independent Director II. NOMINATION & REMUNERATION COMMITTEE: Position in the Name Designation Committee Ms. Archana Bhaskar Chairperson Independent Director Non-Executive Non-Independent Mr. Ankur Nand Thadani Member Director Mr. Nachiket Madhusudan Mor Member Independent Director Mr. Venkatraman Balakrishnan Member Independent Director III. STAKEHOLDERS RELATIONSHIP COMMITTEE: Position in the Name Designation Committee Mr. Venkatraman Balakrishnan Chairperson Independent Director Ms. Archana Bhaskar Member Independent Director Dr. Adil Agarwal Member Whole-Time Director & CEO IV. CORPORATE SOCIAL RESPONSIBILITY COMMITTEE: Position in the Name Designation Committee Mr. Nachiket Madhusudan Mor Chairperson Independent Director Non-Executive Non-Independent Mr. Ankur Nand Thadani Member Director Dr. Adil Agarwal Member Whole-Time Director & CEO V. RISK MANAGEMENT COMMITTEE: Position in the Name Designation Committee Mr. Nachiket Madhusudan Mor Chairperson Independent Director Non-Executive Non-Independent Mr. Ankur Nand Thadani Member Director Dr. Adil Agarwal Member Whole-Time Director & CEO The requisite details, in terms of regulation 30 read with Schedule III of the SEBI Listing regulations and SEBI Master Circular, concerning the aforesaid cessation of Mr. Sanjay Anand as an Independent Director of the Company, are enclosed herewith as Annexure I. This information is also made available on the website of the Company at: www.dragarwals.co.in We request you to kindly take the above on record. Thanking you, For Dr. Agarwal’s Health Care Limited Thanikainathan Arumugam Company Secretary and Compliance Officer Encl.: as above. ANNEXURE I Details required in terms of regulation 30 read with Schedule III of the SEBI Listing regulations and SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 I. Completion of Tenure of Mr. Sanjay Anand, Independent Director of the Company Particulars Details Cessation due to completion of the second term of Reason for change viz. 5 consecutive years as an Independent Director of appointment, re-appointment, 1. the Company, pursuant to Section 149(11) of the resignation, removal, death or Companies Act, 2013 and Regulation 25 of the SEBI otherwise; Listing Regulations. Date of appointment / re- appointment / cessation (as 2. Close of business hours on September 29, 2026 applicable) & term of appointment / re-appointment Brief profile (in case of 3. N.A. appointment) Disclosure of relationships 4. be tween directors (in case of N.A. appointment of a director)